Oncolytic adenovirus gene therapy (Multivir)

N/A

Report date: 2023/10/26 16:14:47

Base Information

Drug NameOncolytic adenovirus gene therapy (Multivir)

Drug Alias NameAd5-VirRx 007Ad-VirRx 007Ad-VirRx 007 -MultiVirAd5-VirRx-007Ad-VirRx-007-MultiVir +[6]

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector

Mechanisms of ActionApoptosis regulatory proteins stimulantsGene transference

TargetsAdenovirus death proteinApoptosis regulatory proteins

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesMultivir Inc

China Registration ClassN/A

Active CompaniesMultivir Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A